2型糖尿病患者将基础胰岛素治疗转换为基础胰岛素支持的口服格列尼特和α-葡萄糖苷酶抑制剂治疗的疗效取决于胰岛素分泌能力，而不取决于转换前的血糖状况和胰岛素剂量

IF 1.3 Q4 ENDOCRINOLOGY & METABOLISM

Diabetology International Pub Date : 2023-09-04 DOI:10.1007/s13340-023-00651-z

Toshihito Ando, Masaki Kondo, Yuriko Asada-Yamada, Miyuka Kawai, Emi Asano-Hayami, Tomohide Hayami, Mikio Motegi, Yohei Ejima, Eriko Nagao, Rina Kasagi, Hiromi Nakai-Shimoda, Saeko Asano, Makoto Kato, Yuichiro Yamada, Emiri Yura-Miura, Takahiro Ishikawa, Yukako Sugiura-Roth, Chika Kojima, Ena Naito, Tatsuhito Himeno, Shin Tsunekawa, Yoshiro Kato, Jiro Nakamura, Hideki Kamiya

{"title":"2型糖尿病患者将基础胰岛素治疗转换为基础胰岛素支持的口服格列尼特和α-葡萄糖苷酶抑制剂治疗的疗效取决于胰岛素分泌能力，而不取决于转换前的血糖状况和胰岛素剂量","authors":"Toshihito Ando, Masaki Kondo, Yuriko Asada-Yamada, Miyuka Kawai, Emi Asano-Hayami, Tomohide Hayami, Mikio Motegi, Yohei Ejima, Eriko Nagao, Rina Kasagi, Hiromi Nakai-Shimoda, Saeko Asano, Makoto Kato, Yuichiro Yamada, Emiri Yura-Miura, Takahiro Ishikawa, Yukako Sugiura-Roth, Chika Kojima, Ena Naito, Tatsuhito Himeno, Shin Tsunekawa, Yoshiro Kato, Jiro Nakamura, Hideki Kamiya","doi":"10.1007/s13340-023-00651-z","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"54 1","pages":"0"},"PeriodicalIF":1.3000,"publicationDate":"2023-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The efficacy of switching basal–bolus insulin therapy to basal insulin-supported oral therapy with a glinide and an α-glucosidase inhibitor in patients with type 2 diabetes depends on insulin secretory capacity, but not on blood glucose profiles and insulin dosages prior to the switching\",\"authors\":\"Toshihito Ando, Masaki Kondo, Yuriko Asada-Yamada, Miyuka Kawai, Emi Asano-Hayami, Tomohide Hayami, Mikio Motegi, Yohei Ejima, Eriko Nagao, Rina Kasagi, Hiromi Nakai-Shimoda, Saeko Asano, Makoto Kato, Yuichiro Yamada, Emiri Yura-Miura, Takahiro Ishikawa, Yukako Sugiura-Roth, Chika Kojima, Ena Naito, Tatsuhito Himeno, Shin Tsunekawa, Yoshiro Kato, Jiro Nakamura, Hideki Kamiya\",\"doi\":\"10.1007/s13340-023-00651-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11340,\"journal\":{\"name\":\"Diabetology International\",\"volume\":\"54 1\",\"pages\":\"0\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2023-09-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetology International\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s13340-023-00651-z\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetology International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13340-023-00651-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The efficacy of switching basal–bolus insulin therapy to basal insulin-supported oral therapy with a glinide and an α-glucosidase inhibitor in patients with type 2 diabetes depends on insulin secretory capacity, but not on blood glucose profiles and insulin dosages prior to the switching

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Diabetology International ENDOCRINOLOGY & METABOLISM-

CiteScore

3.90

自引率

4.50%

发文量

期刊介绍： Diabetology International, the official journal of the Japan Diabetes Society, publishes original research articles about experimental research and clinical studies in diabetes and related areas. The journal also presents editorials, reviews, commentaries, reports of expert committees, and case reports on any aspect of diabetes. Diabetology International welcomes submissions from researchers, clinicians, and health professionals throughout the world who are interested in research, treatment, and care of patients with diabetes. All manuscripts are peer-reviewed to assure that high-quality information in the field of diabetes is made available to readers. Manuscripts are reviewed with due respect for the author''s confidentiality. At the same time, reviewers also have rights to confidentiality, which are respected by the editors. The journal follows a single-blind review procedure, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. Single-blind peer review is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.